Centre Hospitalier Régional d'Orléans   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Orléans France (1000)

Organization Overview

First Clinical Trial
2013
NCT01817153
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Régional d'Orléans | CHR d'Orléans | Hospital Regional Center of ORLEANS | Immunologie et Neurogénétique Expérimentales et Moléculaires (INEM)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Shock (Phase 3)

Shock, Septic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 10